We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.54B
AUM Growth
+$120M
Cap. Flow
-$6.56M
Cap. Flow %
-0.43%
Top 10 Hldgs %
29.96%
Holding
232
New
47
Increased
111
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$31.9M
2
LW icon
Lamb Weston
LW
+$24.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.1M
4
GS icon
Goldman Sachs
GS
+$17.5M
5
FCNCA icon
First Citizens BancShares
FCNCA
+$16.3M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$31.8M
2
SNPS icon
Synopsys
SNPS
+$26.6M
3
KIM icon
Kimco Realty
KIM
+$23.1M
4
NI icon
NiSource
NI
+$21.1M
5
UNP icon
Union Pacific
UNP
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.76%
2 Technology 16.54%
3 Financials 14.35%
4 Industrials 13.12%
5 Consumer Staples 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PWR icon
1
Quanta Services
PWR
$100B
$73.3M 4.76%
514,191
+4,415
+0.9% +$627K
UNH icon
2
UnitedHealth
UNH
$376B
$62.7M 4.08%
118,305
+2,303
+2% +$1.22M
MRK icon
3
Merck
MRK
$322B
$53.4M 3.47%
480,867
+311,855
+185% +$31.9M
KLAC icon
4
KLA
KLAC
$239B
$47.4M 3.08%
1,257,690
+6,340
+0.5% +$221K
TMUS icon
5
T-Mobile US
TMUS
$185B
$44.5M 2.89%
318,003
+10,492
+3% +$1.51M
DVN icon
6
Devon Energy
DVN
$52.1B
$37.7M 2.45%
613,669
+5,827
+1% +$397K
RTX icon
7
RTX Corp
RTX
$290B
$36.3M 2.36%
359,530
-2,495
-0.7% -$235K
KEYS icon
8
Keysight
KEYS
$54.5B
$35.5M 2.31%
207,447
+46,668
+29% +$7.96M
LPLA icon
9
LPL Financial
LPLA
$28.3B
$35.1M 2.29%
162,588
+975
+0.6% +$228K
TRV icon
10
Travelers Companies
TRV
$78.1B
$34.9M 2.27%
186,079
+1,327
+0.7% +$239K
COR icon
11
Cencora
COR
$60.6B
$34.6M 2.25%
208,744
+1,502
+0.7% +$237K
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$121B
$34.4M 2.24%
119,115
+59,543
+100% +$18.1M
CTVA icon
13
Corteva
CTVA
$52.6B
$34.4M 2.24%
584,824
-12,561
-2% -$795K
PFE icon
14
Pfizer
PFE
$143B
$34.1M 2.22%
665,620
+1,736
+0.3% +$83.2K
ON icon
15
ON Semiconductor
ON
$31.8B
$33.2M 2.16%
532,253
+6,973
+1% +$465K
HSY icon
16
Hershey
HSY
$35.5B
$31.8M 2.07%
137,413
+1,353
+1% +$312K
ENPH icon
17
Enphase Energy
ENPH
$4.96B
$27.4M 1.78%
103,570
+1,487
+1% +$433K
SYY icon
18
Sysco
SYY
$40.8B
$27.2M 1.77%
355,152
+355
+0.1% +$28.7K
BLDR icon
19
Builders FirstSource
BLDR
$7.15B
$26.7M 1.74%
411,858
+7,994
+2% +$499K
LW icon
20
Lamb Weston
LW
$7.22B
$25.3M 1.65%
+283,180
New +$24.1M
OKE icon
21
Oneok
OKE
$57.2B
$24.7M 1.6%
375,541
+1,555
+0.4% +$95.6K
COST icon
22
Costco
COST
$422B
$24.3M 1.58%
53,153
-248
-0.5% -$121K
MET icon
23
MetLife
MET
$61.9B
$24.1M 1.57%
332,672
+2,056
+0.6% +$147K
WMB icon
24
Williams Companies
WMB
$87.5B
$23.9M 1.55%
726,319
+13,822
+2% +$450K
APH icon
25
Amphenol
APH
$198B
$21.7M 1.41%
568,968
+98,072
+21% +$3.71M
1
2 3 4 5

Similar funds

MB
MUFG Bank Tokyo 100-8388,, Japan $3.04B AUM 15.55% 1-Year Est. Return
MCM
MKP Capital Management New York $3.04B AUM 20.46% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return

Cookson Peirce & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Cookson Peirce & Co held 232 positions worth $1.54B, up 8.4% from $1.42B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cookson Peirce & Co's Q4 2022 filing shows 47 new, 111 increased, 37 reduced and 30 closed positions. Its largest new stake was Lamb Weston: 283,180 shares worth $25.3M. The largest sale was AstraZeneca, an estimated $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Cookson Peirce & Co's largest Q4 2022 buy was Lamb Weston: 283,180 shares worth $25.3M.
  • Cookson Peirce & Co added most to Merck in Q4 2022, an estimated $31.9M increase.
  • Cookson Peirce & Co's biggest Q4 2022 reduction was AstraZeneca, cutting an estimated $31.8M.
  • Cookson Peirce & Co fully exited Synopsys in Q4 2022, selling an estimated $26.6M.
  • Cookson Peirce & Co's ten largest holdings make up 30% of its $1.54B portfolio in Q4 2022.
  • Cookson Peirce & Co opened 47 new positions and closed 30 in Q4 2022.
  • Cookson Peirce & Co's portfolio value rose 8.4% quarter-over-quarter to $1.54B.

Based on Cookson Peirce & Co's 13F filing for Q4 2022, filed 31 Jan 2023.